BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lee HW, Park JY, Ahn SH. An evaluation of entecavir for the treatment of chronic hepatitis B infection in adults. Expert Rev Gastroenterol Hepatol 2016;10:177-86. [PMID: 26610256 DOI: 10.1586/17474124.2016.1125781] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Chen R, Wang T, Song J, Pu D, He D, Li J, Yang J, Li K, Zhong C, Zhang J. Antiviral Drug Delivery System for Enhanced Bioactivity, Better Metabolism and Pharmacokinetic Characteristics. Int J Nanomedicine 2021;16:4959-84. [PMID: 34326637 DOI: 10.2147/IJN.S315705] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
2 Luo A, Jiang X, Ren H. Entecavir-based combination therapies for chronic hepatitis B: A meta-analysis. Medicine (Baltimore) 2018;97:e13596. [PMID: 30572464 DOI: 10.1097/MD.0000000000013596] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Othumpangat S, Ray SD, Noti JD. Antiviral Drugs. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions. Elsevier; 2017. pp. 269-82. [DOI: 10.1016/bs.seda.2017.07.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
4 Cojocaru FD, Botezat D, Gardikiotis I, Uritu CM, Dodi G, Trandafir L, Rezus C, Rezus E, Tamba BI, Mihai CT. Nanomaterials Designed for Antiviral Drug Delivery Transport across Biological Barriers. Pharmaceutics 2020;12:E171. [PMID: 32085535 DOI: 10.3390/pharmaceutics12020171] [Cited by in Crossref: 63] [Cited by in F6Publishing: 47] [Article Influence: 31.5] [Reference Citation Analysis]
5 Cheng D, Han B, Zhang W, Wu W. Clinical effects of NTCP-inhibitor myrcludex B. J Viral Hepat 2021;28:852-8. [PMID: 33599010 DOI: 10.1111/jvh.13490] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Ray G. 5-year efficacy of entecavir in Indian patients with chronic hepatitis B. Indian J Gastroenterol 2016;35:190-4. [PMID: 27216583 DOI: 10.1007/s12664-016-0664-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]